Coherus BioSciences
CHRS
$2.07
Share price
1.47%
Change (1 day)
-71.37%
Change (1 year)
Categories
Coherus BioSciences (CHRS) - Total assets
Total assets on the balance sheet as of December 2023 : $0.62 B
According to Coherus BioSciences 's latest financial reports the company's total assets are $0.62 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Coherus BioSciences - Total assets on balance sheet (from 2013 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $0.48 B | -29.22% |
| 2021-12-31 | $0.67 B | -19.29% |
| 2020-12-31 | $0.84 B | 105.82% |
| 2019-12-31 | $0.40 B | 311.12% |
| 2018-12-31 | $99.46 M | -38.83% |
| 2017-12-31 | $0.16 B | -8.89% |
| 2016-12-31 | $0.17 B | -15.96% |
| 2015-12-31 | $0.21 B | 13.44% |
| 2014-12-31 | $0.18 B | 294.59% |
| 2013-12-31 | $47.44 M | 78.82% |
| 2012-12-31 | $26.53 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $97.15 B | 15,330.97% | 🇺🇸 USA |
 Repligen
RGEN | $2.82 B | 348.60% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.10 B | -82.76% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | N/A | N/A | 🇺🇸 USA |